Tau-based biomarker tracks Alzheimer’s progression

Kanta Horie, PhD, works with a mass spectrometer that he uses to measure protein levels in cerebrospinal fluid samples. Horie and colleagues at Washington University School of Medicine in St. Louis and Lund University in Sweden have discovered that a form of the protein tau in the cerebrospinal fluid known as MTBR-tau243 can be used to track the progression of Alzheimer's disease and could speed drug development. Read Entire Article

© 2024 Thiratti. All rights reserved.